| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | -43.8% |
| Cost of Revenue | $3.0M | -28.9% |
| Gross Profit | $923K | -66.3% |
| R&D Expense | $215K | -33.9% |
| SG&A Expense | $2.9M | +4.8% |
| Operating Income | -$3.7M | -111.9% |
| Interest Expense | $8K | — |
| Net Income | -$4.0M | -116.4% |
| EPS (Basic) | -$0.36 |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7K | -98.7% |
| Accounts Receivable | $489K | -64.8% |
| Current Assets | $599K | -73.8% |
| Total Assets | $1.3M | -61.7% |
| Current Liabilities | $4.5M | +117.4% |
| Total Liabilities | $5.4M | +33.8% |
| Stockholders' Equity | -$4.1M | -574.2% |
| Line Item | 2025-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | -32.3% |
| Financing Cash Flow | $1.5M | -5.4% |
| -111.8% |
| EPS (Diluted) | -$0.36 | -111.8% |